Cabot (NYSE:CBT – Get Free Report) issued an update on its FY 2024 earnings guidance on Monday morning. The company provided EPS guidance of 6.650-6.850 for the period, compared to the consensus EPS estimate of 6.650. The company issued revenue guidance of -. Cabot also updated its FY24 guidance to $6.65-6.85 EPS.
Cabot Price Performance
CBT traded up $5.05 during trading on Tuesday, reaching $100.99. The stock had a trading volume of 767,326 shares, compared to its average volume of 308,474. The firm has a market capitalization of $5.60 billion, a price-to-earnings ratio of 13.26, a price-to-earnings-growth ratio of 1.00 and a beta of 1.27. Cabot has a 1-year low of $63.73 and a 1-year high of $103.46. The stock has a 50 day moving average of $90.82 and a two-hundred day moving average of $81.68. The company has a quick ratio of 1.30, a current ratio of 2.04 and a debt-to-equity ratio of 0.74.
Cabot (NYSE:CBT – Get Free Report) last released its quarterly earnings data on Monday, May 6th. The specialty chemicals company reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.66 by $0.12. The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.04 billion. Cabot had a return on equity of 25.52% and a net margin of 11.24%. The firm’s revenue was down 1.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.33 earnings per share. As a group, equities analysts anticipate that Cabot will post 6.58 EPS for the current fiscal year.
Cabot Increases Dividend
Analyst Ratings Changes
Several brokerages have recently issued reports on CBT. Deutsche Bank Aktiengesellschaft lowered shares of Cabot from a buy rating to a hold rating and boosted their price target for the company from $88.00 to $95.00 in a report on Thursday, April 18th. StockNews.com downgraded shares of Cabot from a strong-buy rating to a buy rating in a research note on Wednesday, February 14th. Mizuho raised their price target on shares of Cabot from $104.00 to $109.00 and gave the company a buy rating in a research note on Tuesday. Finally, UBS Group lifted their target price on Cabot from $100.00 to $103.00 and gave the stock a neutral rating in a report on Tuesday. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, Cabot currently has an average rating of Moderate Buy and an average target price of $93.67.
Read Our Latest Stock Report on CBT
Insider Activity
In other news, EVP Jeff Ji Zhu sold 55,233 shares of the stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $79.91, for a total value of $4,413,669.03. Following the completion of the sale, the executive vice president now directly owns 97,201 shares of the company’s stock, valued at $7,767,331.91. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 3.07% of the company’s stock.
About Cabot
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Featured Stories
- Five stocks we like better than Cabot
- How to Find Undervalued Stocks
- Garmin Navigates to New Highs Driven By Wearables Trend
- Bank Stocks – Best Bank Stocks to Invest In
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- Overbought Stocks Explained: Should You Trade Them?
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.